Insider trades
Christopher Causey, Director of United Therapeutics UTHR, has filed 0 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $2.3M. The latest trade was on 03/30.
Christopher Causey
Director
- Company
- United Therapeutics UTHR
- First filing
- 23/01/03
- Trades
- 55 trades
- Buys / sales
- 0 / 18
- 12-month net buying
- −$2.3M
- Last trade
- 03/30
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 03/30 | 03/31 | 1,300 sh | $604.64 | $786,032 | −23.7% | |
| Open-market sale10b5-1 plan | 03/04 | 03/05 | 20 sh | $490.17 | $9,803.4 | −0.5% | |
| Open-market sale10b5-1 plan | 02/25 | 02/25 | 1,000 sh | $520.00 | $520,000 | −19.3% | |
| Open-market sale10b5-1 plan | 01/06 | 01/06 | 1,000 sh | $510.00 | $510,000 | −19.3% | |
| Open-market sale10b5-1 plan | 01/02 | 01/05 | 1,000 sh | $500.01 | $500,010 | −19.3% | |
| Open-market sale | 25/09/24 | 25/09/25 | 1,000 sh | $440.00 | $440,000 | −17.1% | |
UTHR | Open-market sale10b5-1 plan | 25/09/02 | 25/09/02 | 3,000 sh3 trades | $423.21avg. | $1,269,630 | −38.1% |
| Open-market sale | 24/11/01 | 24/11/04 | 510 sh | $376.63 | $192,081.3 | −12.2% | |
| Open-market sale | 24/08/21 | 24/08/22 | 1,210 sh | $349.00 | $422,290 | −22.4% | |
| Open-market sale | 24/06/18 | 24/06/20 | 3,000 sh | $304.18 | $912,540 | −41.8% | |
| Open-market sale | 24/06/13 | 24/06/14 | 2,000 sh | $281.53 | $563,060 | −32.3% | |
| Open-market sale | 24/05/15 | 24/05/16 | 2,000 sh | $272.90 | $545,800 | −32.3% | |
| Open-market sale | 24/05/03 | 24/05/06 | 2,240 sh | $259.91 | $582,198.4 | −34.9% | |
| Open-market sale | 23/12/15 | 23/12/18 | 400 sh | $255.00 | $102,000 | −8.7% | |
| Open-market sale | 23/12/12 | 23/12/13 | 3,000 sh | $249.68 | $749,040 | −39.6% | |
| Open-market sale | 23/01/03 | 23/01/03 | 1,000 sh | $276.26 | $276,260 | −26.1% |